Bullboard - Stock Discussion Forum COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone... see more

Add To Watchlist

TSX:CSCI - Post Discussion

COSCIENS Biopharma Inc > Financial Results

View:

Post by archeo753 on Nov 11, 2024 2:45pm

Financial Results

Posted last year on Nov. 9. So should happen soon. Not expect much but at least we'll get an update. Whatever happened to the increased liquidity we were promised if Ceapro joined the NASDAQ?

Comment

Comment by lscfa on Nov 11, 2024 2:59pm

Gagnon gotta meet Nasdaq deadlines now. No more lax TSXV timing.

Comment

Comment by prophetoffactz on Nov 11, 2024 7:33pm

The next 1 1/2 months is tax loss selling and this stock is down 53% this year. It will be interesting to see how much cash is left. The new Director suggests there could be a strong new President and CEO appointed soon which could be important for the story and a key catalyst. With the avenanthramide clinical trial expected to complete the 2 dose portion of the Phase I portion of the clinical ...more

Comment

Comment by Stinzo on Nov 12, 2024 2:47am

The company has no credibility and no shareholder support especially because, Insiders at all levels do not support the company, as it has no clear path forward (latest release mentions awaiting new CEO for new strategy) it has been loss making and with failed trials for way too long it holds some decent cash which it is holding to its chest to pay its employees even though ...more

Comment